Adherence biomarker measurements in older and younger HIV-infected adults receiving tenofovir-based therapy
Journal of Acquired Immune Deficiency Syndromes Feb 16, 2018
Seifert SM, et al. - Researchers here assessed longitudinal tenofovir (TFV) and tenofovir diphosphate (TFV-DP) concentrations in hair and dried blood spots (DBSs), respectively, from HIV-infected adults. They observed that younger and older HIV-infected individuals on TFV-based therapy showed comparable cumulative drug exposure measures (hair and DBS) after adjustment for renal function.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
